Doximity, Inc. Class A Common Stock (DOCS)
31.82
-1.36 (-4.10%)
NYSE · Last Trade: Nov 6th, 12:53 PM EST
News & Press Releases
DOCS Class Action Lead Plaintiff Deadline is November 16, 2026 - Contact Robbins LLP About Leading the Case Against Doximity, Inc.
San Diego, California--(Newsfile Corp. - November 6, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Doximity, Inc. (NYSE: DOCS) common stock between August 8, 2024 and May 13, 2026, inclusive (the "Class Period"). Doximity is a digital platform for medical professionals that combines health care news, workflow products, and clinician networking.
Via Newsfile · November 6, 2026
Doximity (DOCS) Q2 2027 Earnings Call Transcriptfool.com
Health system AI adoption climbed sharply, while accuracy and data security emerged as key concerns.
Via The Motley Fool · November 6, 2026
DOCS Q3 CY2026 deep dive: AI-driven product expansion meets margin compression
Medical professional network Doximity (NYSE:DOCS) reported calendar Q3 2026 (fiscal Q2 2027) results beating Wall Street’s revenue expectations, with sales u...
Via StockStory · November 6, 2026
Doximity (NYSE:DOCS) Shares Fall on Soft Guidance and Margin Pressurechartmill.com
Via Chartmill · November 5, 2026
DOCS INVESTOR ALERT: Bragar Eagel & Squire, P.C. Urges Doximity, Inc. Investors to Contact the Firm Before November 16th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Doximity (DOCS) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 5, 2026
Doximity’s (NYSE:DOCS) Q3 CY2026 sales beat estimates but stock drops
Medical professional network Doximity (NYSE:DOCS) announced better-than-expected revenue in calendar Q3 2026 (fiscal Q2 2027), with revenue up 3.6% year on y...
Via StockStory · November 5, 2026
Doximity Announces Fiscal 2027 Second Quarter Financial Results
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 second quarter ended September 30, 2026.
By Doximity · Via Business Wire · November 5, 2026
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law
LOS ANGELES, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (NYSE: DOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall, Brown & Schwartz LLP · Via GlobeNewswire · November 5, 2026
DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Doximity, Inc. Investors of Upcoming Deadline
NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) investors of the November 16, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · November 5, 2026
Kaplan Fox Deadline Alert: Doximity, Inc. (NYSE: DOCS) Investors Have Until November 16, 2026 to Seek a Lead Plaintiff Role
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · November 4, 2026
Doximity (DOCS) reports Q3: everything you need to know ahead of earnings
Medical professional network Doximity (NYSE:DOCS) will be reporting earnings this Thursday after market hours. Here’s what to expect. Doximity beat analysts’...
Via StockStory · November 3, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines – DOCS
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · November 3, 2026
DOCS UPCOMING DEADLINE: SueWallSt Alerts Doximity, Inc. Stockholders of Securities Class Action
Key dates and disclosure events shareholders need to know: the securities action chronicles three separate DOCS declines between November 2025 and May 2026 after Doximity allegedly overstated its Newsfeed's revenue impact and its competitive standing
By SueWallSt · Via GlobeNewswire · November 3, 2026
Bragar Eagel & Squire, P.C. Urges Doximity, Inc. Investors to Contact the Firm Before November 16th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Doximity (DOCS) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 2, 2026
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law
LOS ANGELES, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (NYSE: DOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall, Brown & Schwartz LLP · Via GlobeNewswire · November 2, 2026
DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
Doximity co-founder and former Chief Strategy Officer Nate Gross is named as a defendant in a securities class action alleging the Company assured investors it could "gain share" while older advertising formats were allegedly losing ground to programmatic and social competitors.
By Levi & Korsinsky, LLP · Via GlobeNewswire · November 2, 2026
3 unpopular stocks with open questions
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
Via StockStory · November 1, 2026
DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
NEW YORK CITY, NY / ACCESS Newswire / October 30, 2026 / Levi & Korsinsky, LLP notifies investors in Doximity, Inc. (NYSE:DOCS) that a securities class action has been filed on behalf of shareholders who purchased common stock between August 8, 2024 and May 13, 2026, and that co-founder Nate Gross is among the individual defendants named in the action. Find out if you could qualify to recover your per-share losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.
By Levi & Korsinsky, LLP · Via ACCESS Newswire · October 30, 2026
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law
LOS ANGELES, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (NYSE: DOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall, Brown & Schwartz LLP · Via GlobeNewswire · October 29, 2026
Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach Doctors
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, has launched DoseCheck, a free additional safety layer in Doximity Ask that instantly checks every AI-generated medication dosing claim against a structured drug database to reduce treatment errors and increase patient safety.
By Doximity · Via Business Wire · October 29, 2026
Bragar Eagel & Squire, P.C. Urges Doximity, Inc. Investors to Contact the Firm Before November 16th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Doximity (DOCS) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · October 28, 2026
DOXIMITY, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 16, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) investors of the November 16, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · October 28, 2026
Kaplan Fox Urges Doximity, Inc. (NYSE: DOCS) Investors to Contact the Firm Before the Deadline on November 16, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · October 28, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines – DOCS
NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · October 27, 2026
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Doximity, Inc. Lawsuit - DOCS
Doximity reported "record engagement" using metrics of its own design, yet the securities action contends its disclosures omitted the market share erosion and light-engagement advertising methods that were already reshaping DOCS revenue.
By SueWallSt · Via GlobeNewswire · October 27, 2026